Sandra Gottschling
Impact in
-
- Cancer Cells and Metastasis
- Lung Cancer Research Studies
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 8
- Cancer Cells and Metastasis 5
- Lung Cancer Research Studies 2
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Esther Herpel (9 shared papers)Philipp A. Schnabel (9 shared papers)Felix Herth (8 shared papers)Michael Meister (6 shared papers)Michael Thomas (5 shared papers)Thomas Muley (6 shared papers)Anja Seckinger (3 shared papers)Rainer Saffrich (2 shared papers)
- Journals
- Lung Cancer (4 papers)Blood (2 papers)Stem Cells (1 paper)Journal of Clinical Oncology (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)
- Partner nations
- GermanyUnited KingdomPoland
In The Last Decade
Sandra Gottschling
16 papers receiving 422 citations
Peers
Comparison fields: 5 of 63
- Oncology 189
- Cancer Research 101
- Hematology 74
- Genetics 68
- Immunology 91
Countries citing papers authored by Sandra Gottschling
This map shows the geographic impact of Sandra Gottschling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Gottschling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Gottschling more than expected).
Fields of papers citing papers by Sandra Gottschling
This network shows the impact of papers produced by Sandra Gottschling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Gottschling. The network helps show where Sandra Gottschling may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra Gottschling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 70 | |
| 2 | 1998 | 69 | |
| 3 | Are we missing the target? Cancer stem cells and drug resistance in non-small cell lung cancer. | 2013 | 50 |
| 4 | 2008 | 42 | |
| 5 | 2013 | 41 | |
| 6 | The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer. | 2011 | 39 |
| 7 | 2001 | 30 | |
| 8 | 2011 | 25 | |
| 9 | 2012 | 24 | |
| 10 | Lack of prognostic significance of neuroendocrine differentiation and stem cell antigen co-expression in resected early-stage non-small cell lung cancer. | 2013 | 13 |
| 11 | 2012 | 12 | |
| 12 | 2007 | 7 | |
| 13 | 2011 | 6 | |
| 14 | 2009 | 1 | |
| 15 | 2005 | 1 | |
| 16 | 2004 | 1 |
About Sandra Gottschling
Sandra Gottschling is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Genetics, having authored 16 papers that have together received 431 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Lung Cancer Treatments and Mutations (4 papers), Mesenchymal stem cell research (3 papers), Cancer Genomics and Diagnostics (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Lung Cancer Research Studies (2 papers), TGF-β signaling in diseases (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Oncology (189 citations), Cancer Research (101 citations), Hematology (74 citations), Genetics (68 citations) and Immunology (91 citations). Sandra Gottschling has collaborated with scholars based in Germany, United Kingdom and Poland. Frequent co-authors include Esther Herpel, Philipp A. Schnabel, Felix Herth, Michael Meister, Michael Thomas, Thomas Muley, Anja Seckinger, Rainer Saffrich, U. Krause and Anthony D. Ho. Their work appears in journals such as Lung Cancer, Blood, Stem Cells, Journal of Clinical Oncology and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.